HOOK (hookipapharma.com) Net Profit

HOOK (hookipapharma.com) - company brandmark

HOOKIPA Pharma Inc. (HOOK) management effectively contains costs through collaborations, and this chart from the GURU.Markets terminal illustrates the company's excess income, where the current mark is 0.00. The brand's scientific prestige is bolstered by an innovative immunotherapy platform and the trust of industry behemoths. The strategy is completed by adherence to ESG standards through the implementation of energy-saving technologies and laboratory emission purification systems.

HOOK (HOOKIPA Pharma Inc.) Net Profit history from 07/04/2022 to 08/24/2025

Analytical breakdowns and data insights for company hookipapharma.com (HOOK)

- price and consensus price forecast:
Stock Quotes HOOKIPA Pharma|HOOK - Analyst Consensus Forecast
- business market valuation indicators:
Market Capitalization HOOKIPA Pharma Inc.|HOOK - Real Price to Acquire Entire Company
- book capitalization data:
Accounting Value of a Share HOOKIPA Pharma|HOOK - Book Capitalization|Market Capitalization to Book Value hookipapharma.com|HOOK - Aggregate Company Assets
- debt and solvency information:
Total Debt to Equity Ratio HOOKIPA Pharma Inc.|HOOK - Long-Term Debt to Equity|Short-Term Debt to Equity Ratio HOOKIPA Pharma|HOOK - Company Total Debt|Debts to Book Capitalization HOOKIPA Pharma Inc.|HOOK - Company Long-Term Debt|Company Short-Term Indebtedness HOOKIPA Pharma|Immediate Liquidity hookipapharma.com
- net income and valuation multiples indicators:
HOOK - Net Profit
Summary company analysis:HOOKIPA Pharma Inc.
Core merchandise of HOOKIPA Pharma, Inc.

This indicator measures the operational sensitivity of net income to Fed rate dynamics and borrowing costs, allowing for the real-time tracking of financial stability. The decline in profit margins shown on the chart signals an increasing cash deficit, which is critical for HOOKIPA Pharma Inc. (HOOK) due to high R&D expenditure pressure and a reliance on external financing in the absence of revenue.

Main competitors

Net Income argenx BVBA|BNTX (BioNTech SE) - Net Profit|Net Profit Abivax Pharma|Net Income ADMA (ADMA Biologics, Inc.)|PTGX (Protagonist Therapeutics, Inc.) - Final Profit|Net Profit IMVT (Immunovant Corp)|Net Financial Result Kiniksa Corp (KNSA)|GRFS - Company Net Income|adaptivebiotech.com (ADPT) - Net Income|Celldex Therapeutics, Inc. (CLDX) - Company Net Income|Net Income Aurinia Pharmaceuticals Inc|Net Income BCRX|Net Profit Vera Corp|Company Net Income Dianthus Therapeutics (DNTH)|pharvaris.com - Company Profit|Net Profit ABCL (AbCellera Biologics Inc)|Tourmaline Bio Inc (TRML) - Company Net Income|Intrexon - Net Profit|Final Profit PHAR (Pharming Corp)|Nektar Therapeutics (NKTR) - Company Net Income|Company Net Income upstreambio.com (UPB)|Company Net Income Zenas Biopharma|Company Net Income Immunome Inc IMNM|Company Net Income Gossamer Corp (GOSS)|Net Profit KalVista Corp (KALV)|Net Profit SEPN (Septerna Inc)|Net Financial Result pieris.com (PVLA)|SVRA - Company Net Income|Profit After Tax RIGL|ANAB: Net Profit|Astria Corp (ATXS) - Net Profit|Net Income ENGN|RAPT: Final Profit|Company Net Income Aerovate Therapeutics Inc (JBIO)|ACRS: Profit After Tax|Net Profit KYTX (Kyverna)|Final Profit TLSA|Cabaletta Bio, Inc. - Net Profit|VTYX - Net Profit|Theratechnologies (THTX) - Company Net Income|Avalo Therapeutics, Inc. - Final Profit|Company Net Income Eledon|Net Income Agenus, Inc (AGEN)|Net Profit CLYM|Net Profit zurabio.com (ZURA)|aTyr Pharma - Net Income|Final Profit ADAG|Ikena Oncology, Inc. - Net Profit|Net Financial Result Shattuck Labs, Inc. STTK|equilliumbio.com (EQ) - Company Net Income|Company Profit CNTB|IMUX (Immunic Therapeutics) - Net Profit|Net Income Atara Biotherapeutics Inc (ATRA)|Net Income IFRX (InflaRx N.V.)|Net Financial Result X4 Pharmaceuticals, Inc|Net Profit ACET (Adicet Bio, Inc.)|Final Profit CELU|INMB - Company Net Income|Company Net Income Barinthus Biotherapeutics PLC|Kezar Life Sciences, Inc (KZR) - Company Net Income|Company Net Income SAB Biotherapeutics Inc (SABS)|Company Net Income Akari Therapeutics|Net Profit Enlivex Therapeutics, Ltd.|Company Net Income Q32 Bio Inc. (QTTB)|GOVX: Profit After Tax|Net Profit EDSA (Edesa)|Final Profit IBIO|Carisma Tx - Net Profit|XTLB - Net Profit|boltbio.com (BOLT) - Company Net Income|HCW Biologics - Final Profit|Company Net Income Aptevo Therapeutics, Inc.|Net Income aimimmuno.com (AIM)|Net Profit ADTX|Net Profit gribio.com (GRI)|XORTX Therapeutics - Net Income|Final Profit HIND|Revelation Bio - Net Profit|Net Financial Result Indaptus Corp INDP|Scinai Immunotherapeutics (SCNI) - Company Net Income|Net Income CalciMedica|Company Net Income Affimed NV|Net Income Allakos Therapeutics (ALLK)|Net Income IGMS (IGM Biosciences, Inc.)|Net Profit iTeos Pharma (ITOS)|Company Net Income Ocean Biomedical, Inc. OCEA|TCBP: Company Profit|Third Harmonic Bio, Inc. - Net Profit